Please login to the form below
Ipsen appoints Aidan Murphy as EVP, technical operations
He is promoted from senior VP biologics development and manufacturing
Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice president, technical operations.
Murphy, who has more than 25 years of industry experience, joined Ipsen in 2007 and has held a number of manufacturing leadership roles at he firm, with his most recent role being senior vice president biologics development and manufacturing.
David Meek, chief executive officer at Ipsen, said: “Murphy brings outstanding manufacturing leadership experience and an international perspective, having worked across multiple geographies both prior to and during his career with Ipsen.
“He has played an instrumental role in the transformation of Ipsen Technical Operations in recent years, and the continuity of leadership he brings will be critical as we continue our development as a leading global biopharma company.”
Dr Murphy succeeds Jonathan Barnsley as EVP technical operations following Barnsley’s retirement at the end of 2017.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
